We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Evotec Announces Initiation of Phase I Clinical Trial of VR1 Antagonist under Partnership with Pfizer

News   Aug 05, 2008

 
Evotec Announces Initiation of Phase I Clinical Trial of VR1 Antagonist under Partnership with Pfizer
 
 
 

RELATED ARTICLES

Effective Approach to Optimizing Medicinal Molecules Developed

News

Lobachevsky University scientists develop an effective approach to optimizing medicinal molecules, which will significantly accelerate and automate the process of prototype optimization to candidate molecules for subsequent preclinical testing.

READ MORE

Highly Effective and Selective Molecule Developed to Fight Malaria

News

A novel laboratory-synthesized molecule is a strong candidate for the development of a new antimalarial drug.

READ MORE

Science Fans Challenged Once Again to Create the Ultimate Lego Lab

News

Radleys “Build a Lego Lab” competition is back and aims this year to more outlandish, clever and crazy Lego lab creations than ever before.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE